Breaking News
-
AFT offering to treat scars
Tuesday | May 7 2024AFT Pharmaceuticals is set to develop a topical treatment for keloid and hypertrophic scarring in partnership with NZ's Massey Ventures, the commercialisation arm of Massey University, and the Gillies McIndoe Research Institute.
-
Brooke Shelly wins big
Monday | May 6 2024THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
-
PSA’s credentialed members package
Monday | May 6 2024THE Pharmaceutical Society of Australia (PSA) has unveiled a comprehensive membership package designed to provide robust support for credentialed pharmacists throughout their professional journey.
-
Putting patients at the centre
Monday | May 6 2024MEDICAL research produces better outcomes when people with lived experience are involved in the process, according to Breast Cancer Network Australia (BCNA).
-
PD breaking news – 2024 PSA MIMS Credentialed Pharmacist of the Year winner announced
Friday | May 3 2024The recipient of the esteemed award was announced during PSA’s Credentialed Pharmacist Conference in Cairns today.
-
Dementia body’s new face
Friday | May 3 2024DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
-
Many stores still not stocking Naloxone
Friday | May 3 2024NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia's most populous states.
-
Senate inquiry hearing on vaping bill
Thursday | May 2 2024THE Senate's Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
-
Cardiac drug on the PBS
Thursday | May 2 2024PFIZER Australia's Vyndamax (tafamidis) is now listed on the PBS for treating fatal heart conditions related to amyloid disorders.
-
Cardio cuts death by 20%
Thursday | May 2 2024A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.